Draft:Enzyme-linked single molecule array (eSimoa)

Submission declined on 23 August 2024 by Pygos (talk).

This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.

If you would like to continue working on the submission, click on the "Edit" tab at the top of the window.
If you have not resolved the issues listed above, your draft will be declined again and potentially deleted.
If you need extra help, please ask us a question at the AfC Help Desk or get live help from experienced editors.
Please do not remove reviewer comments or this notice until the submission is accepted.

Where to get help

If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews.
If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed.

How to improve a draft

Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia.
Help:Wikitext – how to use the markup
Help:Referencing for beginners – how to include references
Wikipedia:Article development – how to develop your article
Wikipedia:Writing better articles – how to improve your article
Wikipedia:Verifiability – make sure your article includes reliable third-party sources

You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article.

Improving your odds of a speedy review

To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags.

Add tags to your draft

Editor resources

Easy tools: Citation bot (help) | Advanced: Fix bare URLs

Declined by Pygos 2 months ago. Last edited by Pygos 2 months ago. Reviewer: Inform author.

Resubmit

Please note that if the issues are not fixed, the draft will be declined again.

Comment: All of the citations are made regarding the origins of the eSimoa technology, the part of which I don't believe to be of enough significance to be mentioned; all the other technical parts lack citations and are too short to be informative. You should cite more sources and expand the technical parts of this article before submitting it again. If you cannot, then probably this topic lacks notability. Pygos (talk) 08:47, 23 August 2024 (UTC)

eSimoa (enzyme-linked single molecule array) is an advanced diagnostic tool that significantly enhances the sensitivity and resolution of biomolecular detection. This technology is pivotal in fields like clinical diagnostics, drug discovery, and basic biological research due to its ability to detect biomolecules at concentrations previously unachievable with traditional assays.

Technology

The eSimoa platform utilizes paramagnetic beads to attach biomolecules or enzymes, facilitating the measurement of enzymatic reactions at the single-molecule level. This method improves the detection limits for various enzymes and biomolecules, allowing for the precise quantification of low-abundance proteins and the activity of enzymes such as protein kinases and telomerases.

Applications

eSimoa's high sensitivity is particularly beneficial for tracking enzymatic activities and their inhibition, which is crucial for developing new pharmaceuticals and understanding disease mechanisms. Its applications extend to evaluating enzyme inhibitors, providing insights into their effectiveness and potential as therapeutic agents.

Origins

Chi-An Cheng at National Taiwan University (NTU) has claimed that her team developed this innovative technology.^[1]^[2] However, this claim is contested by the existence of prior publications by David R. Walt's team at Harvard University, who published their work on eSimoa in 2020.^[3] This earlier documentation by Walt's team suggests a prior contribution to the development of the technology.

References

^ Cheng, CA (28 November 2023). "eSimoa – ultrasensitive and high-resolution protein spatially decoding framework for tumor extracellular vesicles | Exosome RNA". Exosome RNA.
^ Cheng, Chi-An (13 June 2024). "Voices in Molecular Pharmaceutics : Meet Professor Chi-An Cheng, Who Is Innovating Diagnostic Tools, Discovering Biomarkers, Developing New Assays, and Creating New Materials". Molecular Pharmaceutics. doi:10.1021/acs.molpharmaceut.4c00623. PMID 38869420.
^ Wang, Xu; Ogata, Alana F.; Walt, David R. (2 September 2020). "Ultrasensitive Detection of Enzymatic Activity Using Single Molecule Arrays". Journal of the American Chemical Society. 142 (35): 15098–15106. doi:10.1021/jacs.0c06599. PMC 7472518. PMID 32797755.

[1] Cheng, CA (28 November 2023). "eSimoa – ultrasensitive and high-resolution protein spatially decoding framework for tumor extracellular vesicles | Exosome RNA". Exosome RNA.

[2] Cheng, Chi-An (13 June 2024). "Voices in Molecular Pharmaceutics : Meet Professor Chi-An Cheng, Who Is Innovating Diagnostic Tools, Discovering Biomarkers, Developing New Assays, and Creating New Materials". Molecular Pharmaceutics. doi:10.1021/acs.molpharmaceut.4c00623. PMID 38869420.

[3] Wang, Xu; Ogata, Alana F.; Walt, David R. (2 September 2020). "Ultrasensitive Detection of Enzymatic Activity Using Single Molecule Arrays". Journal of the American Chemical Society. 142 (35): 15098–15106. doi:10.1021/jacs.0c06599. PMC 7472518. PMID 32797755.

[1]

[2]

[3]